How does HHBT's PB Ratio compare to its peers?

Insufficient data to calculate HHBT's Price-To-Book Ratio vs. peers for valuation analysis.

How does HHBT's PB Ratio compare vs other companies in the US Real Estate Industry?

Insufficient data to calculate HHBT's Price-To-Book Ratio vs. industry for valuation analysis.

What is HHBT's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

Insufficient data to calculate HHBT's Price-To-Book Fair Ratio for valuation analysis.

What is the Fair Price of HHBT when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Insufficient data to calculate HHBT's fair value for valuation analysis.

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Insufficient data to show price forecast.

HH Biotechnology Holdings (OTCPK:HHBT) - Stock Price, News & Analysis

HHBT Stock Overview

Engages in health and green industries. More details

HHBT fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($1K)

Latest financial reports are more than a year old

Shares are highly illiquid

HH Biotechnology Holdings Company Competitors

Advanced Oxygen Technologies

OTCPK:AOXY

US$210.7k

Green Giant

OTCPK:GGEI

US$28.7k

Bengal Steel Industries

BSE:512404

₹245.0k

Ucommune International

NasdaqCM:UK

US$1.8m

Price History & Performance

Summary of all time highs, changes and price drops for HH Biotechnology Holdings
Historical stock prices
Current Share Price	US$0.0001
52 Week High	US$0.0001
52 Week Low	US$0.0001
Beta	0
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	-99.93%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	HHBT	US Real Estate	US Market
7D	0%	5.7%	2.2%
1Y	n/a	29.1%	31.6%

Return vs Industry: Insufficient data to determine how HHBT performed against the US Real Estate industry.

Return vs Market: Insufficient data to determine how HHBT performed against the US Market.

Price Volatility

Is HHBT's price volatile compared to industry and market?
HHBT volatility
HHBT Average Weekly Movement	n/a
Real Estate Industry Average Movement	7.6%
Market Average Movement	6.3%
10% most volatile stocks in US Market	15.7%
10% least volatile stocks in US Market	3.1%

Stable Share Price: HHBT's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine HHBT's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1987	n/a	Sheng Jiang	www.greatchinaholdings.com

HH Biotechnology Holdings Company engages in health and green industries. It focuses on planting and supplying macadamia nuts for use in foods, cooking oils, healthy products, toiletries, and cosmetics. The company was formerly known as Great China International Holdings, Inc. and changed its name to HH Biotechnology Holdings Company in August 2016.

HH Biotechnology Holdings Company Fundamentals Summary

How do HH Biotechnology Holdings's earnings and revenue compare to its market cap?
HHBT fundamental statistics
Market cap	US$1.41k
Earnings (TTM)	US$2.88m
Revenue (TTM)	US$7.95m

0.0x

P/E Ratio

0.0x

P/S Ratio

Is HHBT overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
HHBT income statement (TTM)
Revenue	US$7.95m
Cost of Revenue	US$5.18m
Gross Profit	US$2.77m
Other Expenses	-US$107.02k
Earnings	US$2.88m

Last Reported Earnings

Sep 30, 2016

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did HHBT perform over the long term?

See historical performance and comparison